A. MDR-TB facilities and specialists in the country | B. Treatment outcome data collection methods | C. Available guidance and protocols for management MDR-TB patients | D. Health system organisation and financing | E. Health and social system organisation | F. Health system regulation with regard to TB and MDR-TB treatment | G. Availability and uninterrupted supply of MDR-TB drugs | H. Public health information approaches for preventions and control of MDR-TB | I. Behaviour and attitude of healthcare workers towards MDR-TB treatment | |
---|---|---|---|---|---|---|---|---|---|
Country’s health system organisation and MDR-TB situation | 1,8 | 32 | |||||||
Service delivery | |||||||||
-Diagnosis of MDR and XDR-TB | 21–23 | ||||||||
-MDR-TB treatment | 25,26 | ||||||||
-(Duration of) Hospitalisation | 2–4,9 | ||||||||
-Teamwork and multidisciplinary teams | 24,28–30 | ||||||||
-Cross-border MDR-TB case management | |||||||||
Health workforce | 5,6,10 | 31 | 40–46 | 56–57 | |||||
Health information | 13–20 | ||||||||
Medical products, vaccines and technologies | 27 | 50–54 | |||||||
Sustainable financing and social protection | 33–39 | ||||||||
Leadership and governance | 7,11 | 47–49 | 55 |